Prevalence of Borrelia miyamotoi in Ixodes Ticks in Europe and the United States
Chris D. Crowder, Heather E. Carolan, Megan A. Rounds, Vaclav Honig, Benedikt Mothes, Heike Haag, Oliver Nolte, Ben J. Luft, Libor Grubhoffer, David J. Ecker, Steven E. Schutzer, and Mark W. Eshoo
Author affiliations: Ibis Biosciences, Carlsbad, California, USA (C.D. Crowder, H.E. Carolan, M.A. Rounds, D.J. Ecker, M.W. Eshoo); Biology Centre ASCR, Ceske Budejovice, Czech Republic (V. Honig, L. Grubhoffer); Laboratory of Dr. Brunner, Constance, Germany (B. Mothes, H. Haag, O. Nolte); University of Tübingen, Tübingen, Germany (B. Mothes); Zentrum für Labormedizin, St. Gallen, Switzerland (O. Nolte); State University of New York at Stony Brook School of Medicine, Stony Brook, New York, USA (B.J. Luft); Rutgers New Jersey Medical School, Newark, New Jersey, USA (S.E. Schutzer)
Main Article
Table 2
Borrelia miyamotoi PCR/ESI-MS basecount signatures*
Region |
Genotype |
BCT3515 (rplB) |
BCT3517 (flaB) |
BCT3519 (hbb) |
BCT3520 (hbb) |
BCT3511 (gyrB) |
Europe |
1 |
A13G22C15T18 |
A41G30C23T27 |
A41G29C19T46 |
A52G29C13T47 |
A36G32C13T35 |
North America |
2 |
A13G22C15T18 |
A43G28C23T27 |
A40G30C18T47 |
A52G30C13T46 |
A37G31C13T35 |
Japan |
3 |
A13G22C15T18 |
A41G29C23T28 |
A40G30C18T47 |
A53G29C13T46 |
A37G31C13T35 |
Main Article
Page created: September 12, 2014
Page updated: September 12, 2014
Page reviewed: September 12, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.